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Summary
The discovery of biomarkers able to predict biological age of
individuals is a crucial goal in aging research. Recently, research-
ers’ attention has turn toward epigenetic markers of aging. Using
the Illumina Infinium HumanMethylation450 BeadChip on whole
blood DNA from a small cohort of 64 subjects of different ages,
we identified 3 regions, the CpG islands of ELOVL2, FHL2, and
PENK genes, whose methylation level strongly correlates with
age. These results were confirmed by the Sequenom’s EpiTYPER
assay on a larger cohort of 501 subjects from 9 to 99 years,
including 7 cord blood samples. Among the 3 genes, ELOVL2
shows a progressive increase in methylation that begins since the
very first stage of life (Spearman’s correlation coefficient = 0.92)
and appears to be a very promising biomarker of aging.
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Aging is a complex process characterized by a global decline in
physiological functions and is associated with an increased risk for
several diseases. A great effort is made to find reliable biomarkers of
aging and epigenetic represents one of the most promising fields
(Berdasco & Esteller, 2012). Epigenome-wide association studies (EWAS)
report that CpG island, mainly placed within genes promoter regions,
are hypermethylated in the elderly (Bell et al., 2012). In this study, we
analyzed the whole blood DNA methylation profile of 32 mother–
offspring couples using Illumina Infinium HumanMethylation450
BeadChip. The age range was 42–83 and 9–52 years for mothers and
offspring, respectively. ANOVA analysis identified 163 CpG sites differen-
tially methylated between these two groups. The top 5 significant loci
mapped within the CpG islands of ELOVL2, FHL2 and PENK genes, and
other loci within ELOVL2 and PENK had a P-value below the Bonferroni
threshold (Fig. 1A,B). The CpG islands of ELOVL2, FHL2, and PENK – all
located in the respective gene promoter – resulted hypermethylated in
mothers compared with offspring (Fig. 1C), with no sex or family-
associated bias. Spearman’s correlation analysis for the 3 genes showed
striking correlation values between methylation levels and age of the
subjects.
We replicated these results in a larger sex-balanced cohort using
Sequenom’s EpiTYPER assay. The analyzed samples included whole
blood DNA from 494 individuals (245 men and 249 women) ranging
from 9 to 99 years, plus 7 cord-blood DNA samples (3 males and 4
females). Depending on the sequence, the EpiTYPER assay returns the
methylation values of single CpGs or small groups of close CpGs (CpG
units). Samples were divided in 5 age classes, whose mean methylation
values for each CpG unit are reported in Fig. 2A. We then calculated
Spearman correlation between age and methylation level for each
CpG unit. The highest correlation values obtained were 0.92 (CpG_
11.12.13.14), 0.80 (CpG_9.10 and CpG_19.20), and 0.63 (CpG_23.24)
for ELOVL2, FHL2, and PENK, respectively (Fig. 2B). In all cases, the
considered sites tended to be hypermethylated with advancing age
(Fig. 2C, for FHL2 only the CpG_9.10 is shown). ELOVL2 displayed the
widest methylation range, from 7% to 91% (for FHL2 and PENK, they
were 12% to 53% and 1% to 27%, respectively, Fig. 2C).
In each gene, we identified a subset of CpG units, which displayed
high coefficients of correlation with age and whose methylation values
were closely correlated with each other (Fig. 2D). The subset of highly
correlated CpG units was used to perform principal components analysis
(PCA). The first principal component (PC1) was calculated, and boxplot
distributions of PC1 values in the 10 decades of age (Fig. 2E) showed an
increase in methylation level of the considered regions.
In this study, we identified and validated 3 genes, ELOVL2, FHL2, and
PENK, whose CpG islands methylation changes with age. FHL2 and PENK
showed very high correlation values, but with a small difference between
the different age classes. At variance, ELOVL2 displayed not only striking
correlation levels, but also an almost ‘on-off’ methylation trend between
the two extremes of life, ranging from 7% to 91% of methylation.
The hypermethylation of CpG islands during aging is well described
(Bell et al., 2012), and several DNA methylation biomarkers displaying a
good correlation with age have been described (Bocklandt et al., 2011).
In our study, taking advantage of a more dense DNA methylation
microarray technology, we identified and validated more striking and
reproducible age biomarkers. To date, the lack of highly reproducible
aging biomarkers is explained by the high levels of heterogeneity of
aging phenotypes (Cevenini et al., 2008), and only within this frame-
work it is possible to appreciate the extraordinary, progressive hyper-
methylation of ELOVL2 that continuously increases from the very first
stage of life to nonagenarians. We cannot exclude that this is due to
numerical alterations of specific blood cell subpopulations, and further
studies are needed to clarify this issue. Nevertheless, it is worth noting
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that in previous studies of gene expression in T cells, correlations with
gene expression patterns and changes of T subpopulations with age
were not observed (Remondini et al., 2010).
ELOVL2 encodes for a transmembrane protein involved in the
synthesis of long (C22 and C24) x3 and x6 polyunsaturated fatty acids
(PUFA) (Leonard et al., 2002), and it is mainly expressed in the liver,
while its expression and role in human blood cells have not been properly
addressed. Genome-wide studies identified ELOVL2 genetic variants
associated with serum metabolic profile, especially with the serum
concentration of specific n-3 PUFAs (Tanaka et al., 2009; Lemaitre et al.,
2011). To date, ELOVL2 has not been associated with aging. In light of
our results, and considering that PUFAs are involved in crucial biological
functions including energy production, modulation of inflammation, and
maintenance of cell membrane integrity, it is possible that ELOVL2
methylation plays a role in the aging process through the regulation of
different biological pathways.
The outstanding results obtained on ELOVL2 make it a strong
candidate for forensic applications aimed at identifying proband age. To
this purposes, other tissues, such as saliva and hair, should be
investigated. Secondly, ELOVL2 age-dependent hypermethylation is also
a promising candidate as biomarker for the evaluation of individual
fitness in elder people, with the potential for early diagnosis of age-
related diseases or for monitoring therapeutic intervention or disease
course.
In conclusion, (i) DNA methylation of CpG islands of ELOVL2, FHL2,
and PENK shows strong correlation with age and, in particular ELOVL2 is
the most extreme example of age-related hypermethylation, constituting
a bridge between the first developmental stages and the aging process.
(ii) ELOVL2 could be used in forensic sciences and in clinical applications.
(iii) Finally, ELOVL2 could be proposed as a sort of rheostat for aging –
the more is methylated, the more aged is the subject. Further studies are
needed to understand whether ELOVL2 hypermethylation only
represents an indicator of chronological age or rather is functionally
correlated with physiological status and specific clinical conditions.
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Fig. 1 EWAS study. (A) Manhattan plot of
genome-wide P-values from mother–
offspring comparison. (B) P-values and
Spearman correlation values of the selected
CpG sites in ELOVL2, FHL2, and PENK CpG
islands. The P-value of each probe was
ranked from the smallest to the largest, and
the position of the selected probes in the
list is reported in the first column.
(C) Methylation of the selected CpG sites
respect to age. Circles: mothers; triangles:
offspring.
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Fig. 2 Replication study. (A) Mean methylation values ± standard deviation in 5 age classes are reported for each CpG unit. (B) Spearman’s correlation coefficients for each
CpG unit. Highly correlated regions are marked in gray. (C) Methylation values of the CpG unit that better correlates with age in each gene. (D) Correlation between CpG
units within each CpG island. The most correlated CpG units are highlighted in yellow. (E) Distribution of PC1 values calculated in 10 age classes.
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